Gelincik Aslı, İşsever Halim, Unal Derya, Işık Erol, Demirturk Mustafa, Gül Hülya, İliaz Raim, Kara Erdal, Ertek Belkıs, Özşeker Ferhan, Çolakoğlu Bahattin, Büyüköztürk Suna
Division of Allergy, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Department of Public Health, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Allergol Int. 2015 Jan;64(1):35-40. doi: 10.1016/j.alit.2014.10.001. Epub 2014 Oct 13.
There are scarce data about the prevalence of Hymenoptera venom allergy in the general population. The aim of this study was to determine the prevalence of Hymenoptera venom allergy in the general adult population of Istanbul.
A total of 17,064 randomly selected telephone numbers were contacted and 11,816 (69.25%) individuals who agreed to participate completed a questionnaire. Those who disclosed hypersensitivity reactions due to Hymenoptera stings in this initial survey were called again and given another questionnaire. Those who were suspected of experiencing hypersensitivity reactions to Hymenoptera stings were invited for a clinical investigation with in vivo and in vitro diagnostic tests.
According to the first questionnaire, a total of 1171 (9.9%; 95% CI: 9.38-10.47%) were suspected of having a hypersensitivity to Hymenoptera stings. 51.75% (n: 606) answered the second questionnaire and 21% (n: 128) of these were still suspected of having a hypersensitivity to Hymenoptera stings (1.1%; 95% CI: 0.9-1.29%). The confirmed prevalence of hypersensitivity to Hymenoptera stings according to skin tests and in vitro sIgE levels was 0.2% (95% CI: 0.14-0.30%). Nearly all of the participants with systemic reactions were admitted to the emergency department, although only one tenth of them received adrenaline in the emergency room. 2.3% carried an adrenaline injector, whereas none of the patients received venom immunotherapy.
The prevalence of Hymenoptera sting reactions in our geographical region is comparable with other European studies. There is a need to increase the awareness of adrenaline in the emergency management of insect sting anaphylaxis and venom immunotherapy in the prophylaxis.
关于普通人群中膜翅目昆虫毒液过敏的患病率的数据稀缺。本研究的目的是确定伊斯坦布尔普通成年人群中膜翅目昆虫毒液过敏的患病率。
总共联系了17064个随机选择的电话号码,11816名(69.25%)同意参与的个体完成了一份问卷。在初次调查中披露因膜翅目昆虫叮咬而出现过敏反应的人再次被联系并收到另一份问卷。那些被怀疑对膜翅目昆虫叮咬有过敏反应的人被邀请进行体内和体外诊断测试的临床调查。
根据第一份问卷,共有1171人(9.9%;95%置信区间:9.38 - 10.47%)被怀疑对膜翅目昆虫叮咬过敏。51.75%(n = 606)回答了第二份问卷,其中21%(n = 128)仍被怀疑对膜翅目昆虫叮咬过敏(1.1%;95%置信区间:0.9 - 1.29%)。根据皮肤试验和体外sIgE水平,确诊的膜翅目昆虫叮咬过敏患病率为0.2%(95%置信区间:0.14 - 0.30%)。几乎所有有全身反应的参与者都被送往急诊科,尽管其中只有十分之一的人在急诊室接受了肾上腺素治疗。2.3%的人携带肾上腺素注射器,而没有患者接受毒液免疫治疗。
我们地理区域中膜翅目昆虫叮咬反应的患病率与其他欧洲研究相当。有必要提高在昆虫叮咬过敏的急诊管理中对肾上腺素的认识以及在预防中对毒液免疫治疗的认识。